Coultreon
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune disease.
$125M Series A ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMar 16, 2026 (8 months old)
About Coultreon
Our pipeline targets SIK3 to deliver transformative therapies where unmet need remains high.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $125M | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- FKFabrice Kolb Head of Immunology Co-foundersource: coultreon.com
GP
Guy Peeters Chief Financial Officer Co-founderLinkedIn · source: coultreon.comJG
John-Paul Gallivan Head of Development Co-founderLinkedIn · source: coultreon.comMD
Marie De Vulder Chief Legal Officer Co-founderLinkedIn · source: coultreon.comPR
Pierre Raboisson Chief Executive Officer Chief Scientific Officer Co-founderLinkedIn · source: coultreon.com- PPPieter Peeters Operating & Technology Officer Co-foundersource: coultreon.com
Companies like Coultreon
AActio Biosciences$66M Series B+ · Jun 2025
LLocus BiosciencesSeries B+ · Feb 2024
LLifeMine Therapeutics$75M Series B+ · Aug 2026
AAlzheon$100M Series B+ · Apr 2022
BBeeline Medicines$426.3M Series A · Jul 2026IIDRx$120M Series B+ · Aug 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/coultreon (get a free API key).